Get the Stockscreener App
0.6297
6.69%
0.0395
After Hours:
.60
-0.0297
-4.72%
Dariohealth Corp stock is traded at $0.6297, with a volume of 83,029.
It is up +6.69% in the last 24 hours and down -9.51% over the past month.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
See More
Previous Close:
$0.5902
Open:
$0.619
24h Volume:
83,029
Relative Volume:
0.12
Market Cap:
$24.53M
Revenue:
$20.35M
Net Income/Loss:
$-59.43M
P/E Ratio:
-0.6114
EPS:
-1.03
Net Cash Flow:
$-30.96M
1W Performance:
-3.91%
1M Performance:
-9.51%
6M Performance:
-38.86%
1Y Performance:
-52.65%
1-Day Range:
$0.6151
$0.649
1-Week Range:
$0.5684
$0.6677
52-Week Range:
$0.56
$1.9298
Dariohealth Corp Stock (DRIO) Company Profile
Name
Dariohealth Corp
Sector
Industry
Phone
972-4-770-6377
Address
322 W 57TH ST. #33B, NEW YORK
Compare DRIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRIO
Dariohealth Corp
|
0.6297 | 24.53M | 20.35M | -59.43M | -30.96M | -1.03 |
|
VEEV
Veeva Systems Inc
|
226.54 | 37.08B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
57.95 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
49.89 | 8.13B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
88.74 | 7.54B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.33 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Dariohealth Corp Stock (DRIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-25 | Downgrade | TD Cowen | Buy → Hold |
| May-13-22 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Apr-22-21 | Initiated | Cowen | Outperform |
| Mar-23-21 | Initiated | Stifel | Buy |
| Feb-25-21 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-01-21 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Aug-17-20 | Initiated | Aegis Capital | Buy |
| Aug-29-17 | Initiated | Aegis Capital | Buy |
| May-09-16 | Initiated | Rodman & Renshaw | Buy |
View All
Dariohealth Corp Stock (DRIO) Latest News
DarioHealth (NASDAQ:DRIO) Stock Passes Below 200-Day Moving Average – Here’s Why - Defense World
DarioHealth (DRIO) Upgraded to Strong Buy: Here's What You Should Know - MSN
Market Alert: Hinge Health's Multi-Billion Dollar Expected IPO Highlights 600% Valuation Opportunity for DarioHealth - Sharewise
C O R R E C T I O N -- DarioHealth Corp./ -February 06, 2025 at 08:30 am EST - Marketscreener.com
DarioHealth granted extension to regain Nasdaq compliance By Investing.com - Investing.com South Africa
DarioHealth (DRIO) to Release Earnings on Thursday - Defense World
DarioHealth granted extension to regain Nasdaq compliance - Investing.com
DarioHealth (NASDAQ:DRIO) Stock Price Crosses Below 200 Day Moving Average – Here’s Why - Defense World
DarioHealth Reports Strong Revenue Growth in 2024 - TipRanks
DarioHealth Announces New Agreement with a Large Regional Health Plan - Longview News-Journal
DarioHealth Appoints New Auditing Firm PwC Member - TipRanks
DarioHealth (NASDAQ:DRIO) Price Target Lowered to $2.00 at Stifel Nicolaus - Defense World
DarioHealth’s Earnings Call Highlights Robust Growth - TipRanks
Stifel cuts DarioHealth stock target to $2, maintains buy rating - Investing.com
Stifel cuts DarioHealth stock target to $2, maintains buy rating By Investing.com - Investing.com South Africa
DarioHealth Corp. (NASDAQ:DRIO) Q4 2024 Earnings Call Transcript - Insider Monkey
DarioHealth revenue increases 32.9% to USD 27M in 2024 - Medical Buyer
DarioHealth’s Balanced Outlook: Promising Growth Amidst Uncertainties Justifies Hold Rating - TipRanks
Market News Alert: DarioHealth Beats Q4 Expectations, Reports 398% Growth in B2B Recurring Revenue - sharewise
Earnings call transcript: DarioHealth Q4 2024 beats EPS expectations By Investing.com - Investing.com Canada
Earnings call transcript: DarioHealth Q4 2024 beats EPS expectations - Investing.com India
DarioHealth Corp reports results for the quarter ended December 31Earnings Summary - TradingView
DarioHealth earnings beat by $0.15, revenue topped estimates - Investing.com
DarioHealth Reports Fourth Quarter and Full year 2024 Financial and Operating Results - GuruFocus.com
DARIOHEALTH Earnings Results: $DRIO Reports Quarterly Earnings - Nasdaq
DarioHealth Expects To Realize Additional 20% Reduction In Operating Expenses Between Q4 2025 & Q4 2025 - MarketScreener
DarioHealth to Report Fourth Quarter and Full Year 2024 Results on Monday, March 10, 2025 - Marketscreener.com
DarioHealth Corp. SEC 10-K Report - TradingView
DarioHealth Corp. to Host Earnings Call - ACCESS Newswire
Dario Expands Behavioral Health Offerings to Include a Provider Network Through Strategic Arrangement with Rula - GuruFocus.com
DarioHealth (DRIO) Expected to Announce Earnings on Monday - Defense World
DarioHealth adds major healthcare system to client roster By Investing.com - Investing.com South Africa
DarioHealth adds major healthcare system to client roster - Investing.com
Dario Signs First Healthcare System as Employer Contract, Expanding Market Presence and Recurring Revenue Growth - PR Newswire
DarioHealth expands board with healthcare veteran Larry Leisure By Investing.com - Investing.com Australia
Dariohealth Corp Stock (DRIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.57%
2.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):